Portfolio company
INEYE Therapeutics
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
2 investors
Sectors
About
This company develops ocular drug delivery inserts to treat chronic eye conditions such as dry eye and glaucoma for patients.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Perfuse Therapeutics
The company develops sustained-release intravitreal therapies to treat ischemia-driven ocular diseases for patients with conditions like glaucoma and diabetic retinopathy.
Graybug Vision
The company develops sustained-release injectable medicines for patients with retinal diseases and glaucoma to reduce the frequency of ocular treatments.
Biophta
This company develops self-administered ocular inserts providing seven-day continuous drug release for patients with glaucoma and macular oedema.
Eyexora
This company develops therapeutics and medical devices for ophthalmic diseases to treat patients with vision-threatening conditions.
Healome Therapeutics
The company develops eye-drop matrix technology to improve drug delivery and treatment for patients with ocular surface diseases.
Tavo Biotherapeutics
The company develops topical and injectable treatments for patients with glaucoma and retinal diseases.
EyeYon
This company develops synthetic corneal implants and therapeutic contact lenses for patients with corneal diseases, providing alternatives to traditional donor tissue transplants.
Envisia
This clinical-stage biotechnology company develops extended-release ocular therapies for patients with glaucoma and other eye disorders.